関連レポート

肝細胞増殖因子（HGF）の世界市場：2034年予測

出版元：Transparency Market Research  出版元について

発行年：2024年6月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 134ページになります。

商品コード：TMR289

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

上皮成長因子(EGF)の世界市場規模は2023年で11億ドル、2034年に37億ドル、市場の平均年成長率は11.3%にて増加する見込みです。

当レポートでは、上皮成長因子(EGF)の市場予測-2034年、各種セグメント別市場分析(EGFタイプ別、用途別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。


【レポート構成概要】
■上皮成長因子(EGF)の世界市場予測2020-2034年
・市場規模(US$)

■EGFタイプ別、市場-2034年
・TGF-α
・アンフィレグリン
・エピレグリン
・ベータセルリン
・その他
※(市場規模US$)

■用途別、市場-2034年
・スキンケア製品
・創傷治癒
・がん治療
・自己免疫疾患
・再生医療
・その他
※(市場規模US$)

■エンドユーザー別、市場-2034年
・病院
・専門クリニック
・その他（研究所、美容クリニックなど）
※(市場規模US$)　

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■上皮成長因子(EGF)の主要企業プロフィール動向
Johnson & Johnson
Amgen Inc.
Novartis AG
Merck & Co., Inc.
F. Hoffmann-La Roche AG
GSK plc
AstraZeneca plc
Bayer AG
AbbVie Inc.
（全134頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Epidermal Growth Factors (EGFs) Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Epidermal Growth Factors (EGFs) Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Type of EGFs
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of EGFs, 2020-2034
6.3.1. TGF-alpha
6.3.2. Amphiregulin
6.3.3. Epiregulin
6.3.4. Betacellulin
6.3.5. Others
6.4. Market Attractiveness Analysis, by Type of EGFs

7. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Skincare Products
7.3.2. Wound Healing
7.3.3. Cancer Therapy
7.3.4. Autoimmune Disorders
7.3.5. Regenerative Medicine
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
8.4. Market Attractiveness Analysis, by End-user

9. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Epidermal Growth Factors (EGFs) Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type of EGFs, 2020-2034
10.3.1. TGF-alpha
10.3.2. Amphiregulin
10.3.3. Epiregulin
10.3.4. Betacellulin
10.3.5. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Skincare Products
10.4.2. Wound Healing
10.4.3. Cancer Therapy
10.4.4. Autoimmune Disorders
10.4.5. Regenerative Medicine
10.4.6. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type of EGFs
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country

11. Europe Epidermal Growth Factors (EGFs) Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type of EGFs, 2020-2034
11.3.1. TGF-alpha
11.3.2. Amphiregulin
11.3.3. Epiregulin
11.3.4. Betacellulin
11.3.5. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Skincare Products
11.4.2. Wound Healing
11.4.3. Cancer Therapy
11.4.4. Autoimmune Disorders
11.4.5. Regenerative Medicine
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type of EGFs
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Epidermal Growth Factors (EGFs) Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type of EGFs, 2020-2034
12.3.1. TGF-alpha
12.3.2. Amphiregulin
12.3.3. Epiregulin
12.3.4. Betacellulin
12.3.5. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Skincare Products
12.4.2. Wound Healing
12.4.3. Cancer Therapy
12.4.4. Autoimmune Disorders
12.4.5. Regenerative Medicine
12.4.6. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type of EGFs
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region

13. Latin America Epidermal Growth Factors (EGFs) Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type of EGFs, 2020-2034
13.3.1. TGF-alpha
13.3.2. Amphiregulin
13.3.3. Epiregulin
13.3.4. Betacellulin
13.3.5. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Skincare Products
13.4.2. Wound Healing
13.4.3. Cancer Therapy
13.4.4. Autoimmune Disorders
13.4.5. Regenerative Medicine
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type of EGFs
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Epidermal Growth Factors (EGFs) Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type of EGFs, 2020-2034
14.3.1. TGF-alpha
14.3.2. Amphiregulin
14.3.3. Epiregulin
14.3.4. Betacellulin
14.3.5. Others
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Skincare Products
14.4.2. Wound Healing
14.4.3. Cancer Therapy
14.4.4. Autoimmune Disorders
14.4.5. Regenerative Medicine
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type of EGFs
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Johnson & Johnson
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Amgen Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Novartis AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Merck & Co., Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. F. Hoffmann-La Roche AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. GSK plc
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. AstraZeneca plc
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Bayer AG
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. AbbVie Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview

List of Tables

Table 01: Global Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 02: Global Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 03: Global Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 04: Global Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Region, 2020-2034

Table 05: North America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Country, 2020-2034

Table 06: North America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 07: North America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 08: North America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 09: Europe Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 11: Europe Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 12: Europe Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 15: Asia Pacific Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 16: Asia Pacific Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 17: Latin America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 19: Latin America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 20: Latin America Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Type of EGFs, 2020-2034

Table 23: Middle East & Africa Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 24: Middle East & Africa Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Epidermal Growth Factors (EGFs) Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Epidermal Growth Factors (EGFs) Market Revenue (US$ Bn), by Type of EGFs, 2023

Figure 03: Global Epidermal Growth Factors (EGFs) Market Value Share, by Type of EGFs, 2023

Figure 04: Global Epidermal Growth Factors (EGFs) Market Revenue (US$ Bn), by Application, 2023

Figure 05: Global Epidermal Growth Factors (EGFs) Market Value Share, by Application, 2023

Figure 06: Global Epidermal Growth Factors (EGFs) Market Revenue (US$ Bn), by End-user, 2023

Figure 07: Global Epidermal Growth Factors (EGFs) Market Value Share, by End-user, 2023

Figure 08: Global Epidermal Growth Factors (EGFs) Market Value Share, by Region, 2023

Figure 09: Global Epidermal Growth Factors (EGFs) Market Value (US$ Bn) Forecast, 2020-2034

Figure 10: Global Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 11: Global Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 13: Global Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 14: Global Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Epidermal Growth Factors (EGFs) Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 22: North America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 23: North America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 26: North America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Epidermal Growth Factors (EGFs) Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 31: Europe Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 32: Europe Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 35: Europe Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Epidermal Growth Factors (EGFs) Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 40: Asia Pacific Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 41: Asia Pacific Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 44: Asia Pacific Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Epidermal Growth Factors (EGFs) Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 49: Latin America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 50: Latin America Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 53: Latin America Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Epidermal Growth Factors (EGFs) Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Type of EGFs, 2023 and 2034

Figure 58: Middle East & Africa Epidermal Growth Factors (EGFs) Market Value Share Analysis, by Application, 2023 and 2034

Figure 59: Middle East & Africa Epidermal Growth Factors (EGFs) Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by Application, 2024-2034

Figure 62: Middle East & Africa Epidermal Growth Factors (EGFs) Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る